A major British study on mixing COVID-19 vaccines has found that people had a better immune response when they received a first dose of the AstraZeneca or Pfizer-BioNTech vaccines followed by the Moderna vaccine nine weeks later, the results showed on Monday.
“We found a really good immune response across the board ... in fact, higher than the threshold set by two doses of the Oxford-AstraZeneca vaccine,” said Matthew Snape, the University of Oxford professor behind the trial dubbed Com-COV2.
The findings supporting flexible dosing offer some hope to poor and middle-income countries that might need to combine different brands between the first and second doses if supplies run low or become unstable.
“I think the data from this study will be especially interesting and valuable to low and middle-income countries, where they’re still rolling out the first two doses of vaccines,” Snape said.
“We’re showing ... you don’t have to stick rigidly to receiving the same vaccine for a second dose ... and that if the program will be delivered more quickly by using multiple vaccines, then it is okay to do so,” Snape added.
If the AstraZeneca vaccine is followed by a Moderna or Novavax vaccine, higher antibodies and T-cell responses were induced versus two doses of AstraZeneca, Oxford researchers said.
The study of 1,070 volunteers also found that a dose of the Pfizer-BioNTech vaccine followed by a Moderna vaccine is better than two doses of the Pfizer-BioNTech vaccine.
Pfizer-BioNTech followed by Novavax induced higher antibodies than two doses of AstraZeneca, although two doses of AstraZeneca induced lower antibody and T-cell responses than two doses of Pfizer-BioNTech.
No safety concerns were raised, an Oxford study published in the Lancet medical journal said.
Many countries have been deploying a mix-and-match approach well before robust data were available, as nations were faced with soaring infection numbers, low supplies and slow vaccination rollouts.
Longevity of protection offered by vaccines has been under scrutiny, with booster doses being considered as cases surge. New variants of SARS-CoV-2, including Delta and Omicron, have increased the pressure to speed up vaccination campaigns.
Blood samples from participants were tested against the Wild-Type, Beta and Delta variants, researchers of the Com-COV2 study said, adding that vaccines’ efficacy against the variants had waned, but this was consistent across mixed courses.
Deploying vaccines from different technology platforms — such as Pfizer and Moderna’s mRNA, AstraZeneca’s viral vector and Novavax’s protein-based shot — and within the same schedule is new.
LANDMARK CASE: ‘Every night we were dragged to US soldiers and sexually abused. Every week we were forced to undergo venereal disease tests,’ a victim said More than 100 South Korean women who were forced to work as prostitutes for US soldiers stationed in the country have filed a landmark lawsuit accusing Washington of abuse, their lawyers said yesterday. Historians and activists say tens of thousands of South Korean women worked for state-sanctioned brothels from the 1950s to 1980s, serving US troops stationed in country to protect the South from North Korea. In 2022, South Korea’s top court ruled that the government had illegally “established, managed and operated” such brothels for the US military, ordering it to pay about 120 plaintiffs compensation. Last week, 117 victims
China on Monday announced its first ever sanctions against an individual Japanese lawmaker, targeting China-born Hei Seki for “spreading fallacies” on issues such as Taiwan, Hong Kong and disputed islands, prompting a protest from Tokyo. Beijing has an ongoing spat with Tokyo over islands in the East China Sea claimed by both countries, and considers foreign criticism on sensitive political topics to be acts of interference. Seki, a naturalised Japanese citizen, “spread false information, colluded with Japanese anti-China forces, and wantonly attacked and smeared China”, foreign ministry spokesman Lin Jian told reporters on Monday. “For his own selfish interests, (Seki)
Argentine President Javier Milei on Sunday vowed to “accelerate” his libertarian reforms after a crushing defeat in Buenos Aires provincial elections. The 54-year-old economist has slashed public spending, dismissed tens of thousands of public employees and led a major deregulation drive since taking office in December 2023. He acknowledged his party’s “clear defeat” by the center-left Peronist movement in the elections to the legislature of Buenos Aires province, the country’s economic powerhouse. A deflated-sounding Milei admitted to unspecified “mistakes” which he vowed to “correct,” but said he would not be swayed “one millimeter” from his reform agenda. “We will deepen and accelerate it,” he
Japan yesterday heralded the coming-of-age of Japanese Prince Hisahito with an elaborate ceremony at the Imperial Palace, where a succession crisis is brewing. The nephew of Japanese Emperor Naruhito, Hisahito received a black silk-and-lacquer crown at the ceremony, which marks the beginning of his royal adult life. “Thank you very much for bestowing the crown today at the coming-of-age ceremony,” Hisahito said. “I will fulfill my duties, being aware of my responsibilities as an adult member of the imperial family.” Although the emperor has a daughter — Princess Aiko — the 23-year-old has been sidelined by the royal family’s male-only
RSS